Laboratorios Farma | ROVI - Cost Of Sales

Stock Price
59.95
Daily Change
1.75 3.01%
Monthly
-29.80%
Yearly
13.54%
Q2 Forecast
57.41

Laboratorios Farma reported EUR186.09M in Cost of Sales for its fiscal semester ending in December of 2023.





Cost Of Sales Change Date
Akebia Therapeutics USD 10.34M 441K Dec/2025
Alaunos Therapeutics USD 0 18K Sep/2024
Almirall EUR 191.5M 2.29M Dec/2025
Avita Medical AUD 3.3M 166K Dec/2025
Ionis Pharmaceuticals USD 3M 5M Mar/2026
IQVIA Holdings USD 3.08B 161M Mar/2026
Laboratorios Farma EUR 186.09M 11.06M Dec/2023
Moderna USD 955M 503M Mar/2026
Organon & Co USD 766M 21M Dec/2025
Pharma Mar EUR 3.66M 116K Mar/2026
Revvity USD 323.46M 26.93M Mar/2026
Viatris USD 2.36B 195.9M Mar/2026
Xeris Pharmaceuticals USD 13.66M 49K Dec/2025